Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

Familial Pelger–Huet Anomaly

Authors: Samir S. Shah, Rupali S. Parikh, Lakshmi P. Vaswani, Rajeshree Divkar

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Pelger–Huet anomaly is usually autosomal dominant, although it is likely that new mutations are common. This condition is characterized by granulocytes that are either bilobed or completely unsegmented. Here is a report of a 46 year old Indian lady who presented with fever to the hospital and on evaluation, her peripheral blood smear showed extreme hypolobation of granulocytes. Along with normal appearing neutrophils there were many neutrophils with bilobed and single monolobated nuclei which accounted for 82 % of the neutrophils. After identifying these neutrophilic abnormalities which were suggestive of Pelgeroid changes, the other family members were also screened and were found to be having similar morphologic abnormalities in granulocytes. As these changes were evident in granulocytic leucocytes of the patient as well as her mother, both her sisters and her son, with exception of her brother, the diagnosis of familial Pelger–Huet Anomaly was considered in this case.
Appendix
Available only for authorised users
Literature
1.
go back to reference O’Malley D, Hsi E (2007) Non neoplastic morphologic abnormalities of white blood cells and macrophages. In: Goldblum J (ed) Hematopathology, a volume in the series foundations in diagnostic pathology, 1st edn. Elsevier, Philadelphia, pp 55–66 O’Malley D, Hsi E (2007) Non neoplastic morphologic abnormalities of white blood cells and macrophages. In: Goldblum J (ed) Hematopathology, a volume in the series foundations in diagnostic pathology, 1st edn. Elsevier, Philadelphia, pp 55–66
2.
go back to reference Al-Qaddomi A, Bassma H, Wraikat A et al (2006) Pelger –Huet anomaly first report from Jordan. A case report. JRMS 13(2):54–56 Al-Qaddomi A, Bassma H, Wraikat A et al (2006) Pelger –Huet anomaly first report from Jordan. A case report. JRMS 13(2):54–56
3.
go back to reference Yamasoma Y, Fujji T, Tsuchiatori K (1953) The Pelger–Huet familial anomaly of leukocytes. Blood 8:370–374 Yamasoma Y, Fujji T, Tsuchiatori K (1953) The Pelger–Huet familial anomaly of leukocytes. Blood 8:370–374
4.
go back to reference Johnson CA, Bass D, Trilloy A et al (1980) Functional and metabolic studies of polymorphonuclear leucocytes in the congenital Pelger –Huet anomaly. Blood 55(3):466–469PubMed Johnson CA, Bass D, Trilloy A et al (1980) Functional and metabolic studies of polymorphonuclear leucocytes in the congenital Pelger –Huet anomaly. Blood 55(3):466–469PubMed
5.
go back to reference Rosse W, Gurney C (1959) The Pelger–Huet anomaly in three families and its use in determining the disappearance of transfused neutrophils from the peripheral blood. Blood 14:170–186PubMed Rosse W, Gurney C (1959) The Pelger–Huet anomaly in three families and its use in determining the disappearance of transfused neutrophils from the peripheral blood. Blood 14:170–186PubMed
Metadata
Title
Familial Pelger–Huet Anomaly
Authors
Samir S. Shah
Rupali S. Parikh
Lakshmi P. Vaswani
Rajeshree Divkar
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0508-3

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine